isomaltulose has been researched along with incretins in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa Yanez, RL; Kemper, M; Keyhani-Nejad, F; Pfeiffer, AFH; Pivovarova-Ramich, O; Rudovich, N; Schueler, R | 1 |
1 trial(s) available for isomaltulose and incretins
| Article | Year |
|---|---|
Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction.
Topics: Adult; Case-Control Studies; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Insulin Resistance; Isomaltose; Liver; Male; Middle Aged; Sucrose | 2020 |